Liver health study for adults with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at fatty liver disease in adults with type 1 diabetes. It aims to understand how common it is and what factors might be linked, which could help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with type 1 diabetes.
- You do not have type 2 diabetes.
- You are not currently taking steroid medications (like prednisone).
- You do not drink alcohol heavily or for a long time.
- You have not been diagnosed with other liver diseases (like viral hepatitis or autoimmune liver disease) or serious liver conditions like cirrhosis or liver cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common liver fat build-up is in people with type 1 diabetes. It aims to understand what factors might increase the risk of liver problems.
This trial looks at how common fatty liver disease is in people with type 1 diabetes. Doctors will check your liver with tests to learn more and find out if you might be at risk.
This study measures how “blood fats” move in the body after fasting and controlled eating, comparing people with type 1 diabetes to those without diabetes. It may help researchers understand diabetes-related differences in lipid (fat) handling and improve future treatments.
This study looks at how the liver responds to sugar given through a vein in obese patients with and without a fatty liver condition called MASLD. It may help doctors understand why some people develop liver problems from sugar and fat.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This trial tests if taking butyrate (a gut-healthy substance) or making intensive lifestyle changes can improve fatty liver disease in people with type 1 diabetes. The goal is to see which approach helps the liver most.
Hear when a new MASLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.